Post-Rehab, Morgan Wallen Does Shots, Sings Hits in Joining Luke Bryan for First Major Appearance Since Scandal lmtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lmtonline.com Daily Mail and Mail on Sunday newspapers.
May 11, 2021
Courtesy Photo
The cover of “Khumbu,” by the group Freelance Philosophers, made up of Alpena natives Forrest Maher, Brian Silver, and Matthew Woolman and Chicago’s Jason Hollembeak and North Carolina’s Todd Mayberry.
Three lifelong friends who found their love for music and friendship in Alpena wrote a concept album called “Khumbu” about trekking in the Khumbu Valley to get the best view of the highest mountain in the world.
Forrest Maher, Brian Silver, and Matthew Woolman, all originally from Alpena, together with their longtime friends, Chicago drummer Jason Hollembeak and North Carolina tenor guitarist Todd Mayberry, released their Freelance Philosophers album called “Khumbu” after Maher traveled to Nepal with his wife, Laurie, and trekked to Mt. Everest basecamp.
MedRhythms Launches Clinical Trial of Stroke Asset on Walking Outcomes
MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, announces the launch of a clinical trial that will study MR-010, MedRhythms’ acute stroke asset.
The trial, conducted in partnership with and funded by UMass Memorial Healthcare, will examine the impact of MR-010 on acute stroke walking outcomes.
Led by Dr. Brian Silver, Interim Chair in the UMass Department of Neurology, the trial will assess the feasibility of MR-010 to address walking impairments in those in the acute phase of stroke. It will consist of two phases: the first phase will look at the impact of MR-010 within the acute hospital setting, and the second phase will look at the continued impact of the therapeutic post-discharge, MedRhythms notes in a media release.
MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke
News provided by
Share this article
Share this article
PORTLAND, Maine, April 28, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the launch of a clinical trial that will study MR-010, MedRhythms acute stroke asset. The trial will be in partnership with UMass Memorial Healthcare and will examine the impact of MR-010 on acute stroke walking outcomes.
Stroke is the world s top cause of long-term disability due to the high prevalence of stroke across the globe as well as its devastating health impacts. Over a third of stroke survivors live in the United States and, according to the CDC, approximately 800,000 people in the US suffer a stroke annually.